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Two decades after the discovery that sequence alterations within and around SOX9 cause 
Campomelic Dysplasia (CD) - a rare skeletal malformation syndrome characterized by 
severe bowing of long bones (campomelia), the underlying molecular pathogenesis 
leading to bone dysmorphism remains unclear. SOX9
Y440X
 is the most recurrent mutation 
identified in CD patients. In Sox9
+/Y440X
 mice that recapitulate the human CD syndrome, 
an expanded population of osteoblasts was detected in the bowed tibiae, suggesting a 
causative relationship between altered osteogenesis and campomelia. As hypertrophic 
chondrocytes (HCs) was recently shown as a major source of endochondral osteoblasts, 
we hypothesized that the CD-associated Sox9
Y440X
 mutation may impact this 
chondrocytes-to-osteoblasts lineage progression in causing campomelia. To test this, we 
utilized Col10a1-Cre to conditionally activate the Sox9
Y440X
 mutation in HCs and to trace 
their fates by lineage analyses utilizing fluorescent protein Cre-reporters. Remarkably, 
homozygous mutants expressing Sox9
Y440X
 specifically in HCs were markedly dwarfed 
and exhibited congenital anterolateral bowing of tibiae. While the mutant Sox9
Y440X 
protein did not evidently impair or promote HCs differentiation into osteoblasts, it 
elevated Ihh signaling in the growth plate to induce excessive periosteal ossification. The 
aberrantly formed periosteal mass in consequence caused mispositioning of the primary 
ossification center to prompt campomelia. Intriguingly, genetic inactivation of β-catenin 
in the conditional Sox9
Y440X
 mutants greatly ameliorated campomelia, implying the 
phenotype was consequential to a neomorphic function of Sox9Y440X in enhancing β-
catenin activity. In conclusion, these findings propose that aberrant periosteal ossification 
owing to dysregulation of Hh signaling may underlie campomelia phenotype in CD 
patients. 
